id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2591009,4680713d-bdad-486c-9d8c-1bde890eb590,1T,STEPHANIE A. BURGESS INC,401105595,VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES,2021,first_quarter,PHA,"Issues related to prescription drug importation, fentanyl scheduling, increased funding for law enforcement to combat fentanyl trafficking, combating pill presses, enhanced penalties for wholesale prescription drug trafficking, counterfeit prevention efforts, enforcement against counterfeits, opioid prevention and recovery, WHOIS & Lock and Suspend, Byrne JAG funding.","HOUSE OF REPRESENTATIVES,SENATE",,,0,1,2021-01-20T13:08:09.747000-05:00
2591408,868e1e06-02bf-4f9e-a494-e2810effa5f1,Q1,LUNGREN LOPINA LLC,401103314,AMPAC FINE CHEMICALS,2021,first_quarter,PHA,Fair treatment for US based pharmaceutical ingredients,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2021-04-01T11:46:28.043000-04:00
2591424,68a232a4-7f34-4412-b907-e8f339114120,Q1,PANNONE LOPES DEVEREAUX & O'GARA LLC,401105501,AMGEN,2021,first_quarter,PHA,Prescription drug pricing.,,9000,,0,0,2021-04-01T12:42:33.730000-04:00
2592563,c9913018-55e0-480d-8a76-b91f74848f9d,Q1,PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION,401103605,PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION,2021,first_quarter,PHA,"COVID-19 vaccine & therapeutic production, and pandemic protection.
Pharmaceutical supply chain and domestic manufacturing","HOUSE OF REPRESENTATIVES,SENATE",,50000,0,0,2021-04-07T13:22:30.830000-04:00
2592654,7b2241cd-9c84-44ba-995a-7a8ed296f758,Q1,STONINGTON GLOBAL,401105189,"SORRENTO THERAPEUTICS, INC.",2021,first_quarter,PHA,Regulatory approvals and funding for pharmaceutical products and devices,"Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",150000,,0,0,2021-04-07T19:25:57.163000-04:00
2593192,590cbc34-6857-42cd-917d-6dced46bda70,Q1,PUBLIC CITIZEN,32362,PUBLIC CITIZEN,2021,first_quarter,PHA,"Covid-19 medicine pricing and access, drug price negotiation, biologics exclusivity, NIST legislative package, Pandemic treatment access and affordability act, Pandemic emergency Manufacturing Act, Medicare and Medicaid prescription drug rebates, We PAID act, Empowering Medicare seniors to Negotiate drug Pricing act, global COVID 19 vaccine access, Stop Stalling act, drug price spike excise act, repealing direct to consumer advertisement tax, Stop Price Gouging Act, Preserving access to affordable generics, TRACK act, drug R&D cost transparency, using executive authority to increase vaccine production.","Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Securities & Exchange Commission (SEC),SENATE,White House Office",,90000,0,0,2021-04-12T08:00:37.127000-04:00
2593277,208ea6f7-5298-4ccf-8e1e-dfcd3e91e176,Q1,POLSINELLI PC,314911,"TEVA PHARMACEUTICALS USA, INC.",2021,first_quarter,PHA,"H.R.1319, American Rescue Plan Act
Issues related to pricing, reimbursement, and manufacturing of pharmaceutical products
Review of Administration telehealth policies","HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2021-04-12T10:43:48.120000-04:00
2593585,db53ffda-1bcd-49c1-b6ef-37fcc1b3c9bf,Q1,CONSUMER HEALTHCARE PRODUCTS ASSOCIATION,29403,CONSUMER HEALTHCARE PRODUCTS ASSOCIATION,2021,first_quarter,PHA,OTC switch process -- no bill number,"Commerce, Dept of (DOC),Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of",,111000,0,0,2021-04-12T16:32:21.017000-04:00
2593679,8475240c-235b-44ea-b1d8-2e1082e148d1,Q1,PENN AVENUE PARTNERS,400918672,"ALKERMES, INC.",2021,first_quarter,PHA,Regulatory and legislative issues impacting Alkermes.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2021-04-12T18:08:27.890000-04:00
2594099,99423dd9-ec02-4faf-9401-9838f271af82,1T,AMERICAN SOCIETY OF CONSULTANT PHARMACISTS,3446,AMERICAN SOCIETY OF CONSULTANT PHARMACISTS,2021,first_quarter,PHA,"american rescue plan, S333(nursing home protection act) S784","Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,SENATE",,15000,0,1,2021-04-13T12:03:54.090000-04:00
2594343,ca002339-ad26-4f9c-9d49-5c33678a7060,Q1,MCDERMOTT+ LLC,401103287,ALLIANCE FOR RURAL HOSPITAL ACCESS,2021,first_quarter,PHA,Amendments to Section 340B of the Public Health Service Act regarding eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2021-04-13T15:04:08.467000-04:00
2594426,73f46ee9-48c3-45e0-b017-3dcdd86228f3,Q1,TODD STRATEGY GROUP,401103321,"ALKERMES, INC.",2021,first_quarter,PHA,Prescription drug pricing.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2021-04-13T15:40:28.267000-04:00
2594433,133ce123-779c-4521-9bf3-757a9ecce9ef,Q1,TODD STRATEGY GROUP,401103321,"ALKERMES, INC.",2021,first_quarter,PHA,Prescription drug pricing.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2021-04-13T15:41:31.293000-04:00
2594496,ce66acb3-a22f-44dd-af5e-2e576e4272db,Q1,TODD STRATEGY GROUP,401103321,BIOTECHNOLOGY INNOVATION ORGANIZATION,2021,first_quarter,PHA,Drug pricing and access.,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office",60000,,0,0,2021-04-13T16:28:35.707000-04:00
2594498,0d84fe59-83fc-44dc-b9a8-6d47866c8c2b,Q1,TODD STRATEGY GROUP,401103321,"CAREDX, INC.",2021,first_quarter,PHA,"Immunosuppressive drug coverage implementation.
S.3404: VALID Act of 2020.","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",40000,,0,0,2021-04-13T16:31:37.003000-04:00
2594507,ddd69a44-58a5-482c-b533-c868395f6339,Q1,TODD STRATEGY GROUP,401103321,EMD SERONO INC.,2021,first_quarter,PHA,Drug pricing policy.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2021-04-13T16:34:42.833000-04:00
2594528,68340f09-da59-405c-9c99-a292bc9b66d3,Q1,TODD STRATEGY GROUP,401103321,"GENENTECH, INC.",2021,first_quarter,PHA,"Prescription drug payment reform.
Supply chain.
Strategic National Stockpile.","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2021-04-13T16:46:58.967000-04:00
2594555,c9b1aa30-084c-4840-a0ff-c7ed7a1dc600,Q1,TODD STRATEGY GROUP,401103321,PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA,2021,first_quarter,PHA,"Drug Pricing and Access.
Pharmaceutical Supply Chain.","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2021-04-13T17:07:19.603000-04:00
2594566,1a3dd2ad-ae58-42f4-b1cc-7c3891554d5e,Q1,TODD STRATEGY GROUP,401103321,"US WORLDMEDS, LLC",2021,first_quarter,PHA,Opioid Use Disorder Treatment Policy.,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2021-04-13T17:11:27.133000-04:00
2594585,891e6b8e-a22f-4e52-8c1a-147a0be717eb,Q1,INDEPENDENT PHARMACY COOPERATIVE,313098,INDEPENDENT PHARMACY COOPERATIVE,2021,first_quarter,PHA,"Support regulations/laws that would eliminate pharmacy DIR.
IPC supports Pharmacists as providers under Medicare Part B
IPC supports Pharmacists as Immunizers
IPC supports 340B Program and contract pharmacies
IPC supports Federal Retail Pharmacy COVID-19 Vaccination Program expansion.","Centers For Medicare and Medicaid Services (CMS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE,White House Office",,30000,0,0,2021-04-13T17:30:36.723000-04:00
2594633,8010d9f4-1e6e-4e67-bd1e-0b7d9d35b0b3,Q1,PENN AVENUE PARTNERS,400918672,"UNITEDHEALTH GROUP, INC.",2021,first_quarter,PHA,Pharmacy benefit related issues.,"HOUSE OF REPRESENTATIVES,SENATE,White House Office",90000,,0,0,2021-04-13T18:15:51.647000-04:00
2594716,73a0b68b-ad92-4b4a-bd28-d062feaca632,Q1,OFF HILL STRATEGIES L.L.C.,401103327,FINANCIAL OVERSIGHT AND MANAGEMENT BOARD FOR PUERTO RICO,2021,first_quarter,PHA,Monitored pharmaceutical supply chain legislation/ policies,"HOUSE OF REPRESENTATIVES,SENATE,White House Office",60000,,0,0,2021-04-13T21:17:16.137000-04:00
2594801,055375df-8df2-4ed0-af67-0c54affedfbf,Q1,"PARAGON BIOSCIENCES, LLC",401105338,"PARAGON BIOSCIENCES, LLC",2021,first_quarter,PHA,Issues related to public and private investment in biosciences and R&D,,,,0,0,2021-04-14T09:33:45.827000-04:00
2595207,694534f9-e7ee-4036-93f2-3c561b98c3af,Q1,AARP,1694,AARP,2021,first_quarter,PHA,"Public L.117-2, American Rescue Plan Act of 2021

No bill number - Discussed vaccine coverage, development, approval, funding, distribution and prioritization 

No bill number - Discussed vaccine coverage

No bill number - Discussed drug pricing reforms, including price negotiation, out-of-pocket cap, and inflation-based rebates","Administration for Children & Families (ACF),Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Consumer Financial Protection Bureau (CFPB),Corporation for Natl & Community Service,Defense, Dept of (DOD),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Indian Health Service,Internal Revenue Service (IRS),Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Institutes of Health (NIH),Natl Transportation Safety Board (NTSB),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of the Comptroller of the Currency (OCC),Pension Benefit Guaranty Corporation (PBGC),Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,Veterans Affairs, Dept of (VA),White House Office",,2840000,0,0,2021-04-14T13:14:18.377000-04:00
2595496,dc9ffc56-286e-4c26-9958-dc369654352b,Q1,"CRISPR THERAPEUTICS, INC.",401105184,"CRISPR THERAPEUTICS, INC.",2021,first_quarter,PHA,Coverage & reimbursement for Cell and Gene Therapies,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,100000,0,0,2021-04-14T16:19:10.123000-04:00
2595660,599487bc-9c8f-41e7-9a42-b0c83c3cd6b4,Q1,ACG ADVOCACY,2057,WALGREEN CO.,2021,first_quarter,PHA,"Drug Pricing Policy Issues.
Data privacy and DIR fee reform.
Public Health Crisis.","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2021-04-14T17:34:04.727000-04:00
2595707,2b66b162-e094-4996-910a-f293c218d45a,Q1,RED+BLUE STRATEGIES,400693064,PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA),2021,first_quarter,PHA,"PL 177-2 - The American Rescue Plan Act - Issues related to increasing access to health care coverage, including access to prescription drugs, for Americans with both public and private insurance.

Issues related to Trump-era rules and regulations regarding Medicare rebate policies and PBM transparency.","Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE",70000,,0,0,2021-04-14T18:36:18.757000-04:00
2595709,cbae9e21-927d-4c15-8899-cb8858e838b0,Q1,RED+BLUE STRATEGIES,400693064,PEW CHARITABLE TRUSTS,2021,first_quarter,PHA,"PL 177-2 - The American Rescue Plan Act - Issues related to the increased substance use disorder crisis in America, the need for a more robust pipeline for antibiotics to protect the nation, a more coherent HIT system to ensure robust public data and other related public health issues. 

S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. 

Issues related to ensuring clear information regarding the safety of supplements. 

Issues related to dealing with antimicrobial resistance among the US population.","Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)",60000,,0,0,2021-04-14T19:23:20.097000-04:00
2595721,ef115b3f-2775-46fa-81e8-99303d98485c,Q1,RED+BLUE STRATEGIES,400693064,COHERUS BIOSCIENCES,2021,first_quarter,PHA,"S. 164 - Biosimilars Education Act of 2021 - A bill to raise awareness of the efficacy and promise of biosimilars in the American health care system. 

Issues and policies that incent companies to increase their US footprint and adopt Made in America business practices. 

Policies to help grow the biosimilars marketplace in the United States. 

Policies focused on improving cancer care through access to affordable treatments.","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2021-04-14T20:13:24.497000-04:00
2595780,58fedfd2-cdc3-47be-b7cf-2e2b95b60a1f,Q1,"REPUBLIC CONSULTING, LLC",401016871,IQVIA,2021,first_quarter,PHA,Monitored Health Data Policy.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2021-04-15T08:39:42.810000-04:00
2596177,39277903-a314-4c12-97bf-a6b91c587cbd,Q1,"RUBICON ADVISORS, LLC",315091,CONSCIOUS DISCIPLINE,2021,first_quarter,PHA,Medicare,"HOUSE OF REPRESENTATIVES,SENATE",67500,,0,0,2021-04-15T12:33:29.383000-04:00
2596186,05b057f0-c693-49bc-a7be-93bf20f1a6e9,Q1,"RUBICON ADVISORS, LLC",315091,DYNAVAX TECHNOLOGIES,2021,first_quarter,PHA,"Prescription Drug User Fee, Biomedical Advance Research and Development Authority (BARDA)","HOUSE OF REPRESENTATIVES,SENATE",75000,,0,0,2021-04-15T12:37:32.237000-04:00
2596191,c53959c7-8f0c-49aa-9821-f8baeed37591,Q1,"RUBICON ADVISORS, LLC",315091,"DR. REDDY'S LABORATORIES, LTD",2021,first_quarter,PHA,Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues,"Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",60000,,0,0,2021-04-15T12:40:34.080000-04:00
2596193,23ed0ddd-e69e-45ab-8981-fe10bbaa7abf,Q1,"RUBICON ADVISORS, LLC",315091,"LANNETT COMPANY, INC",2021,first_quarter,PHA,"Medicare and Medicaid, Generic Prescription, COVID-19 Stimulus","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",50000,,0,0,2021-04-15T12:42:35.257000-04:00
2596199,e21c6534-833c-407d-84ad-9603aac144e3,Q1,"RUBICON ADVISORS, LLC",315091,AVET PHARMACEUTICALS,2021,first_quarter,PHA,"GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM, FOOD AND DRUG ADMINISTRATION AND COVID-19 DRUG SHORTAGES","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES",30000,,0,0,2021-04-15T12:44:37.577000-04:00
2596206,d9d0aae7-eddd-42f1-88be-77bea67ef473,Q1,"RUBICON ADVISORS, LLC",315091,"ASCENDIS PHARMA, INC.",2021,first_quarter,PHA,"Food and Drug Administration, Orphan Drugs",Food & Drug Administration (FDA),60000,,0,0,2021-04-15T12:52:40.387000-04:00
2596220,c34b1284-bf9a-49df-9282-aeb1ced07f95,Q1,"KOUNTOUPES DENHAM CARR & REID, LLC",320918,CONSUMER HEALTHCARE PRODUCTS ASSOCIATION,2021,first_quarter,PHA,"General issues related to over the counter pharmaceuticals and pharmaceutical supply chain.  Implementation of the Over the Counter Monograph provisions included in PL 116-136, Coronavirus Aid, Relief and Economic Security Act.  Issues related to supplements.","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2021-04-15T13:00:43.103000-04:00
2596229,36819046-18f6-4d15-a565-f1b753316192,Q1,"RUBICON ADVISORS, LLC",315091,HYPOPARATHYROIDISM ASSOCIATION,2021,first_quarter,PHA,"Rare disease issues
Orphan drugs","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS)",,,0,0,2021-04-15T13:13:47.003000-04:00
2596325,0683667d-8c1b-4b48-bf61-8f2dff90561e,Q1,"KOUNTOUPES DENHAM CARR & REID, LLC",320918,"GLENMARK PHARMACEUTICALS, INC., USA",2021,first_quarter,PHA,"Issues related to H.R. 1319, the American Rescue Plan.  Issues related to affordability, essential medicine manufacturing and supply chain, and pricing of pharmaceuticals.  General issues related to the generic drug industry.","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2021-04-15T14:00:18.890000-04:00
2596389,6471f83a-97bc-4294-b1b9-1a5a742d00ca,Q1,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2021,first_quarter,PHA,Coverage for direct patient care services of qualified clinical pharmacists under Medicare and other public health programs.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,144981,0,0,2021-04-15T14:34:43.143000-04:00
2596671,48c32028-ee05-482f-8820-3818f45f78e1,Q1,CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER,312496,CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER,2021,first_quarter,PHA,340B,"Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",,30890,0,0,2021-04-15T17:01:11.273000-04:00
2596713,b2021dbe-509a-4bdf-85a2-6ae15d211807,Q1,TODD STRATEGY GROUP,401103321,BAYER CORPORATION,2021,first_quarter,PHA,Drug pricing.,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2021-04-15T17:37:23.930000-04:00
2596779,41e2423a-fc21-4068-b974-eb130f4f3bc7,Q1,BROYDRICK & ASSOCIATES,7268,EXELA PHARMA SCIENCES,2021,first_quarter,PHA,"Drug shortages and FDA approval, USTR acceptance.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2021-04-15T18:43:47.097000-04:00
2596794,dc7c05b4-3a58-4f49-a6e5-b769197bdaec,Q1,BROYDRICK & ASSOCIATES,7268,TONIX PHARMACEUTICALS,2021,first_quarter,PHA,Funding new drug for PTSD and COVID 19.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2021-04-15T18:57:53.827000-04:00
2597157,909fc0f9-87cd-4873-8016-70be99794c19,Q1,ASSOCIATION FOR ACCESSIBLE MEDICINES,16032,ASSOCIATION FOR ACCESSIBLE MEDICINES,2021,first_quarter,PHA,"Prescription Drug Costs.
Drug Pricing.
Pharmaceutical Exclusivity.
180-Day Exclusivity.
Forfeiture of 180-Day Exclusivity.
12-Year Exclusivity.
Contract Genericization.
30-Month Stays.
Labeling of Generic Drugs and Biosimilars.
Modern Labeling.
Generic carveouts patent protected information in drug labels, including issues related to GSK v. Teva.
Orange Book.
Drug Shortages.
S.917: Short on Competition Act.
Stockpile of Generic Drugs.
Generic Drug User Fee Amendments (GDUFA).
GDUFA III Negotiations.
Biosimilar User Fee Act (BsUFA).
BsUFA III Negotiations.
Biosimilars Naming.
Biosimilars Insulin.
Pass-through Payments for Biosimilars.
Cost Sharing for Biosimilars.
Implementation of Food and Drug Administration Reauthorization Act (FDARA).
FDA Inspections.
Buy American Proposals.
Issues Related to COVID-19.
Secretary Azar Importation Plan.","Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,U.S. Trade Representative (USTR)",,880000,0,0,2021-04-16T10:45:32.463000-04:00
2597415,9a6e19a7-28cf-4f45-b74a-7aeca10daf3d,Q1,"4C COMMUNICATIONS, INC.",323717,HEALTHCARE LEADERSHIP COUNCIL,2021,first_quarter,PHA,The Treat Act,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2021-04-16T12:03:35.603000-04:00
2597556,793b15c0-d92b-435b-a479-a19d8de96d22,Q1,"MARSHALL & POPP, LLC",401105121,AMGEN USA INC.,2021,first_quarter,PHA,"Issues related to prescription drug value, supply chains, 340B, and the COVID-19 pandemic, including:

*S.Con.Res. 5, fiscal year 2021 budget resolution.

*H.R.1319: American Rescue Plan Act of 2021.","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2021-04-16T12:21:06.410000-04:00
2597626,225badc0-c273-4915-8109-09282cef5b3e,Q1,"MARSHALL & POPP, LLC",401105121,"GENENTECH, INC.",2021,first_quarter,PHA,"Issues related to prescription drug value, supply chains, 340B, and the COVID-19 pandemic, including:

*S.Con.Res. 5, fiscal year 2021 budget resolution.

*H.R.1319: American Rescue Plan Act of 2021.","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2021-04-16T12:34:21.377000-04:00
2597701,1a7fc91c-e94c-4a23-95da-396923f74a50,Q1,COVINGTON & BURLING LLP,11195,1776 PHARMACEUTICALS LLC,2021,first_quarter,PHA,Re-shoring production of essential medicine,"HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2021-04-16T12:52:39.027000-04:00
2597801,6d4d623b-b4d9-4da9-9feb-a24fb29f3119,Q1,"MARSHALL & POPP, LLC",401105121,PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA,2021,first_quarter,PHA,"Issues related to prescription drug value, supply chains, 340B, and the COVID-19 pandemic, including:

*S.Con.Res. 5, fiscal year 2021 budget resolution.

*H.R.1319: American Rescue Plan Act of 2021.","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2021-04-16T13:27:04.867000-04:00
2597815,d111e75f-230f-431c-b266-4aede4ec97aa,Q1,"MARSHALL & POPP, LLC",401105121,"SANOFI U.S. SERVICES, INC.",2021,first_quarter,PHA,"Issues related to prescription drug value, supply chains, 340B, and the COVID-19 pandemic, including:

*S.Con.Res. 5, fiscal year 2021 budget resolution.

*H.R.1319: American Rescue Plan Act of 2021.","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2021-04-16T13:30:08.670000-04:00
2597865,a80ddce7-0f63-434f-905d-99774a2418ca,Q1,LINCOLN PARK GROUP L.L.C.,401104374,CANADIAN INTERNATIONAL PHARMACY ASSOCIATION,2021,first_quarter,PHA,"Support for S. 920/H.R. 2181 - A bill to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals and S. 259/H.R. 832 - Safe and Affordable Drugs from Canada Act; issues related to personal drug importation.","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2021-04-16T13:44:24.673000-04:00
2597881,fd4a8886-3e6e-4359-bffd-fa337a0f7928,Q1,SUMMIT PUBLIC AFFAIRS,401105467,VANDA PHARMACEUTICALS INC.,2021,first_quarter,PHA,"Issues affecting the pharmaceutical industry, including the prescription drug approval process, animal testing, and gastroparesis issues. 
COVID-19 clinical trials.
H.R. 1319, American Rescue Plan Act of 2021.","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2021-04-16T13:47:28.867000-04:00
2598015,de129df1-52e8-4a53-bdb0-6a8b37171f16,Q1,HOGAN LOVELLS US LLP,18422,"ALVOGEN, PHARMA US, INC.",2021,first_quarter,PHA,Issues related to COVID-19,"HOUSE OF REPRESENTATIVES,SENATE",410000,,0,0,2021-04-16T14:20:07.040000-04:00
2598225,27f32965-aec6-49ad-a10a-ea51172baac9,Q1,FAEGRE DRINKER BIDDLE & REATH LLP,12631,NATIONAL ASSOCIATION OF BOARDS OF PHARMACY,2021,first_quarter,PHA,"Medication safety, pharmacy regulation, and the opioid epidemic; prescription drug monitoring programs; COVID-19 response; H.R. 2482, S. 2074 - Mainstreaming Addiction Treatment Act; opposing prescription drug importation.","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2021-04-16T15:15:09.617000-04:00
2598227,6b7b95f1-93e0-42b4-b790-5891b884acf3,Q1,FAEGRE DRINKER BIDDLE & REATH LLP,12631,ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL),2021,first_quarter,PHA,"Illicit prescription drug sales online; rouge internet drug sellers; dangers of counterfeit medicines; risks of drug importation on patient safety; domain name system accountability regarding COVID-19 frauds; WHOIS; Communications Decency Act, Section 230 reform; STOP Act implementation.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",70000,,0,0,2021-04-16T15:16:10.457000-04:00
2598280,33901d14-3e95-465d-a483-10b6d44c3d57,Q1,BUCHANAN INGERSOLL & ROONEY PC,55291,GENERIC ANIMAL DRUG ALLIANCE,2021,first_quarter,PHA,Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry.,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2021-04-16T15:31:24.800000-04:00
2598297,0ecd5a64-dafe-4d76-93cf-aeeaab5cb39e,Q1,340B HEALTH,316434,340B HEALTH,2021,first_quarter,PHA,"The 340B Drug Pricing Program; S.773 - A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes; H.R. 853: Closing Loopholes for Orphan Drugs Act; H.R.1319 - American Rescue Plan Act of 2021.","Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,292698,0,0,2021-04-16T15:36:30.673000-04:00
2598311,f502cd90-ea26-424c-bd91-997ae3000703,Q1,BLUECROSS BLUESHIELD OF TENNESSEE,6440,BLUECROSS BLUESHIELD OF TENNESSEE,2021,first_quarter,PHA,COVID-19 Testing; Vaccine Strategy and Treatment,"HOUSE OF REPRESENTATIVES,SENATE",,351297,0,0,2021-04-16T15:39:35.877000-04:00
2598440,fe311a0f-ea2d-4613-b919-45fc27ad65b3,Q1,AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS,3457,AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS,2021,first_quarter,PHA,"Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, implementation of the Drug Quality and Security Act. Conversation with DEA regulation on Medication-Assisted Treatment and drug shortages. Discussed COVID-19 response recommendations with House and Senate Offices, HHS and its subagencies, and DEA. Contact HHS, House and Senate Offices concerning rule enforcement of the 340B Drug Pricing Program. Contact FDA concerning the practice of White Bagging and Brown Bagging patient medications.","Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,310000,0,0,2021-04-16T16:07:12.943000-04:00
2598588,223f495c-19fb-4af8-8015-8c1fe970734a,Q1,MASSACHUSETTS MEDICAL SOCIETY,23975,MASSACHUSETTS MEDICAL SOCIETY,2021,first_quarter,PHA,"Issues related to prescription drug prices - no specific bill
Issues related to vaccines - no specific bill","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,50000,0,0,2021-04-16T16:49:47.173000-04:00
2598796,fbdead67-adcb-4d3e-9980-1e054b0b2330,1A,BLUECROSS BLUESHIELD OF TENNESSEE,6440,BLUECROSS BLUESHIELD OF TENNESSEE,2021,first_quarter,PHA,COVID-19 Testing; Vaccine Strategy and Treatment,"HOUSE OF REPRESENTATIVES,SENATE",,350000,0,0,2021-04-16T17:59:32.857000-04:00
2599018,25f1bd84-095b-49e4-8725-cd484aa89f12,Q1,FORBES-TATE,400976792,CALIFORNIA LIFE SCIENCES ASSOCIATION,2021,first_quarter,PHA,Issues related to the life sciences industry; Issues related to drug pricing and international reference pricing.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2021-04-17T10:29:10.167000-04:00
2599084,67276655-f868-4b30-9392-33391cddc53c,Q1,FORBES-TATE,400976792,MERCK,2021,first_quarter,PHA,"Issues related to prescription drug pricing, vaccines, animal health, and maternal health.","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2021-04-17T11:12:47.640000-04:00
2599142,c45a85a5-7815-4ba8-85b4-8f86ad517cf9,Q1,FORBES-TATE,400976792,PHRMA,2021,first_quarter,PHA,Issues pertaining to prescription drug pricing.,"HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2021-04-17T11:50:36.587000-04:00
2599499,2cd7ef58-319c-451b-8926-f14c507f2530,Q1,CAPITOL COUNSEL LLC,313715,"EMD SERONO, INC.",2021,first_quarter,PHA,Monitoring and engaging on health policy proposals coming before the House of Representatives and the Administration pertaining to the availability and pricing of prescription drugs.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2021-04-17T16:34:23.210000-04:00
2599516,0f806121-a039-4450-bcfb-bda78c063649,Q1,CAPITOL COUNSEL LLC,313715,VERTEX PHARMACEUTICALS INCORPORATED,2021,first_quarter,PHA,Monitoring and advocacy on matters related to the pharmaceutical industry.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2021-04-17T16:47:26.777000-04:00
2599661,22d83402-0f3c-4a0b-926e-eba44effe71e,Q1,SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING,35968,SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING,2021,first_quarter,PHA,"Compounding, preparation, packaging and dispensing of radiopharmaceuticals","Centers For Medicare and Medicaid Services (CMS),Energy, Dept of,Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Nuclear Regulatory Commission (NRC),Office of Science & Technology Policy (OSTP),SENATE",,48000,0,0,2021-04-18T08:52:14.947000-04:00
2599793,91ea6662-58e6-4931-8fa9-25f6d1ae1d06,Q1,"TARPLIN, DOWNS & YOUNG, LLC",304736,ASTRAZENECA,2021,first_quarter,PHA,"Drug coverage & reimbursement
vaccination

no specific bills, Import Safety, drug development policy, drug shortages, supply chain integrity, Innovation, reimportation, transparency, 340B, pay for delay","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2021-04-18T13:30:57.280000-04:00
2599824,fcee1c35-ff3a-48d0-9d46-d2f208ec2d2e,Q1,"KOUNTOUPES DENHAM CARR & REID, LLC",320918,ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY - GENERIC PHARMACEUTICAL ASSN),2021,first_quarter,PHA,"Issues related to generic pharmaceuticals and biosimilars, including H.R. 928, the BLOCKING Act of 2019.  Reimbursement rate for biosimilars.  Issues related to the implementation of H.R. 133, Consolidated Appropriations Act for Fiscal Year 2021.  Issues related to H.R. 1319, The American Rescue Plan.  Issues related to the pharmaceutical supply chain and domestic manufacturing.  Issues related to H.R. 6179, Increasing Access to Biosimilars Act of 2020, H.R. 4597, the ACCESS Act, and H.R. 4455, the Biosim Act.","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2021-04-18T14:12:06.457000-04:00
2600017,032f8b9b-f73f-4c9f-87a1-23e8e65dc8ca,Q1,"TARPLIN, DOWNS & YOUNG, LLC",304736,BIOTECHNOLOGY INDUSTRY ORGANIZATION,2021,first_quarter,PHA,"H.R. 1319, American Rescue Plan of 2021


no specific bills, Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, patent settlements, break through therapies, Innovation, transparency

no specific bills, Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies, compounding, user fee reauthorization, Innovation","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",80000,,0,0,2021-04-18T17:59:55.807000-04:00
2600242,a0fe9715-3350-46ad-a625-b65c203df59e,Q1,VAN SCOYOC ASSOCIATES,39837,ZEBRA TECHNOLOGIES CORP.,2021,first_quarter,PHA,"Temperature monitoring technology for COVID-19 vaccines, generally

Public Law 117-7, American Rescue Plan Act of 2021, Temperature monitoring technology","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2021-04-19T06:21:57.887000-04:00
2600780,6a80140a-417f-423f-a5cd-0469b2babcad,Q1,ELI LILLY AND COMPANY,13392,ELI LILLY AND COMPANY,2021,first_quarter,PHA,Hospital discounts; 340B program,"Commerce, Dept of (DOC),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)",,1840000,0,0,2021-04-19T09:47:49.270000-04:00
2601148,6a5bed25-7edc-4377-b284-bc2514dda0d9,Q1,UNIVERSITY OF IOWA,49191,UNIVERSITY OF IOWA,2021,first_quarter,PHA,N/A,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE",,80000,0,0,2021-04-19T10:34:06.737000-04:00
2601523,42b7162e-1b5c-4b3e-9666-4575d657af20,Q1,"GOVERNMENT COUNSEL, LLC",401105070,HEALTHCARE DISTRIBUTION ALLIANCE,2021,first_quarter,PHA,"H.R. 768-Block, Report, And Suspend Suspicious Shipments Act of 2021; DEA Proposed Rule on Suspicious Orders of Controlled Substances [85 Fed. Reg. 69282 (November 2, 2020)] Docket No. DEA-437; General issues relating to implementation of Public Law 113-54 (DSCSA).",HOUSE OF REPRESENTATIVES,60000,,0,0,2021-04-19T11:03:31.833000-04:00
2601600,13322c89-3761-467b-8c41-7ecfd0dc2cab,Q1,HANCE SCARBOROUGH,17443,PHRMA,2021,first_quarter,PHA,Patent reform regarding pharmaceutical research & products.,SENATE,30000,,0,0,2021-04-19T11:09:54.877000-04:00
2602328,42caff2d-ddac-4d83-9061-bc8f0ff3af25,1A,ELI LILLY AND COMPANY,13392,ELI LILLY AND COMPANY,2021,first_quarter,PHA,Hospital discounts; 340B program,"Commerce, Dept of (DOC),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)",,1840000,0,0,2021-04-19T12:08:02.790000-04:00
2602619,5a342a79-36e2-44cb-8a10-ff6a580fc84d,Q1,BAVARIAN NORDIC INC.,312257,BAVARIAN NORDIC INC.,2021,first_quarter,PHA,"Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; cancer; PAHPA; Labor-HHS-ED appropriations bills","HOUSE OF REPRESENTATIVES,SENATE",,130000,0,0,2021-04-19T12:32:07.477000-04:00
2602885,8ad55cb6-b5ac-40aa-93f8-fcc7a2041fb7,Q1,THERMO FISHER SCIENTIFIC INC.,323251,THERMO FISHER SCIENTIFIC INC,2021,first_quarter,PHA,Worker training program.,"Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Environmental Protection Agency (EPA),Executive Office of the President (EOP),Food & Drug Administration (FDA),General Services Administration (GSA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,1300000,0,0,2021-04-19T13:02:11.220000-04:00
2603115,c0186c1b-583d-477b-8fcc-c1440e8dd456,Q1,NATIONAL RURAL HEALTH ASSOCATION,53048,NATIONAL RURAL HEALTH ASSOCATION,2021,first_quarter,PHA,The 340B Program and drug pricing,"Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE",,76501,0,0,2021-04-19T13:23:09.367000-04:00
2603310,b744236c-31ab-493b-8f9e-e553b790cbca,Q1,"TARPLIN, DOWNS & YOUNG, LLC",304736,HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.),2021,first_quarter,PHA,"Opioid Abuse - General issues related to opioid abuse (implementation of Public Law 115-271)
Issues related to ARCOS data and suspicious order record requirements and reporting (HR 768) 
Importation of Prescription Drugs (HR 832, HR 2181, S 259, S 920, Public Law 108-173) 
Implementation of Public Law 113-54 (DSCSA)","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2021-04-19T13:43:53.997000-04:00
2603571,dc63d2d7-9fcd-4e6e-9f97-562c841e9565,Q1,HANCE SCARBOROUGH,17443,ALLIANCE FOR PHARMACY COMPOUNDING,2021,first_quarter,PHA,"Issues related to the regulation of pharmacy compounding.

Issues related to preserving patient access to compounded medications.

Fiscal Year 2022 Appropriations","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2021-04-19T14:13:01.597000-04:00
2603864,146e34f8-2d8c-47c0-9c7a-5e0cf7880680,Q1,HANCE SCARBOROUGH,17443,BOEHRINGER INGELHEIM USA CORPORATION,2021,first_quarter,PHA,"Provide ongoing animal health policy monitoring, assessment, and research support.  Telemedicine/telehealth legislation.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2021-04-19T14:36:24.553000-04:00
2603998,16b62b4d-acb3-47d4-a30e-0302ecf7c059,Q1,HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA),28776,HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA),2021,first_quarter,PHA,"Opioid Abuse - General issues related to opioid abuse (implementation of Public Law 115-271)
Issues related to ARCOS data and suspicious order record requirements and reporting 
Importation of Prescription Drugs (HR 832, HR 2181, S 259, S 920, Public Law 108-173) 
Implementation of Public Law 113-54 (DSCSA) 
Block, Report, and Suspend Suspicious Shipments Act of 2021 (HR 768)","Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,278719,0,0,2021-04-19T14:43:53.827000-04:00
2604078,76ae5829-d1a0-4e6c-bb41-4a08bf881d0e,1T,BUCHANAN INGERSOLL & ROONEY PC,55291,"PHARMACEUTICAL ASSOCIATES, INC.",2021,first_quarter,PHA,Strategy development and implementation of company's federal government relations initiatives.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,1,2021-04-19T14:50:16.577000-04:00
2604277,2944f5ad-0b3d-4be3-903f-ae72f9a2ef29,Q1,WAXMAN STRATEGIES,401103693,340B HEALTH,2021,first_quarter,PHA,Issues affecting the 340B drug pricing program; Appropriations for 340B program.,"HOUSE OF REPRESENTATIVES,SENATE",45000,,0,0,2021-04-19T15:08:06.547000-04:00
2604501,0a5e098f-5cd4-49e4-80e9-c39f4acb74c4,Q1,"M.J. SIMON & COMPANY, LLC",40026223,NOBELPHARMA AMERICA,2021,first_quarter,PHA,FDA inspections,"HOUSE OF REPRESENTATIVES,SENATE",5000,,0,0,2021-04-19T15:27:01.557000-04:00
2604528,643af1d6-0730-484e-990c-1cdbda9fbfc6,Q1,WINNING STRATEGIES WASHINGTON,50796,KALEO,2021,first_quarter,PHA,"Pharmaceutical drug development, including epinephrine for anaphylaxis; drug access and affordability issues","Federal Emergency Management Agency (FEMA),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2021-04-19T15:29:08.120000-04:00
2604595,8dda7526-a7a7-4642-8468-2dd9bd94edd9,Q1,"BOCKORNY GROUP, INC.",289773,CVS HEALTH INC,2021,first_quarter,PHA,"Issues related to PBMs
Issues related to drug pricing
Issues related to Veterans health
Issues related to opioid abuse
Issues related to health reform proposals
Issues related to the ""Gag Rule"" bill
Issues related to dialysis reimbursements
Issues related to representation in COVID-19-related packages
H.R. 133 Consolidated Appropriations Act, 2021","Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",80000,,0,0,2021-04-19T15:34:22.953000-04:00
2604874,3007b2f3-a7a7-4b40-9a8a-a05942519174,Q1,ARTEMIS POLICY GROUP LLC,401105617,AMERICAN SOCIETY OF HEMATOLOGY,2021,first_quarter,PHA,FDA policies related to research and approvals of treatments for hematological diseases,"Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",45000,,0,0,2021-04-19T15:55:19.570000-04:00
2604942,b32fcda3-af9a-432c-b213-52673bc01718,Q1,"ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)",400762305,AMERISOURCEBERGEN CORPORATION,2021,first_quarter,PHA,"Issues related to drug pricing and transparency, generally.
Issues related to the importation of prescription medicines
Issues related to the pharmaceutical supply chain and stockpiling
Issues related to COVID vaccine distribution","HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2021-04-19T15:58:34.120000-04:00
2604945,2c5aa288-94f7-4cca-a6ce-47af877529e5,Q1,ARTEMIS POLICY GROUP LLC,401105617,THE HEMOPHILIA ALLIANCE,2021,first_quarter,PHA,Issues related to participation in the 340B Drug Discount Program,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",42000,,0,0,2021-04-19T15:58:34.607000-04:00
2605002,af14d68b-14fd-4232-a1bb-5adade1829e7,Q1,ARTEMIS POLICY GROUP LLC,401105617,NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION),2021,first_quarter,PHA,"Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Natl Institutes of Health (NIH),SENATE",51000,,0,0,2021-04-19T16:02:48.210000-04:00
2605105,06672678-0605-437c-852f-8bad538c1d8a,Q1,"MUSCULAR DYSTROPHY ASSOCIATION, INC.",400348610,"MUSCULAR DYSTROPHY ASSOCIATION, INC.",2021,first_quarter,PHA,"Advocated for provisions that enable ongoing access to necessary medications and treatments for neuromuscular disease patients throughout theCOVID-19 pandemic. 

Advocated for the reintroduction of the ACT for ALS, legislation that should accelerate development of treatments for individuals with ALS and other neuromuscular diseases.","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Federal Aviation Administration (FAA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT)",,100000,0,0,2021-04-19T16:10:09.200000-04:00
2605299,f18992dd-f902-4265-b1c7-53a4176d2965,Q1,THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH,401104060,THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH,2021,first_quarter,PHA,General education around pharmaceuticals related to Parkinson's disease,"Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,25000,0,0,2021-04-19T16:23:48.927000-04:00
2605459,fe851c86-99df-4ddf-a9d3-f457b2853686,Q1,NATIONAL ASSOCIATION OF CHAIN DRUG STORES,26672,NATIONAL ASSOCIATION OF CHAIN DRUG STORES,2021,first_quarter,PHA,"Interfaced with the White House, Operation Warp Speed; HHS Secretary and team, and CDC to drive COVID testing & vaccinations across the nation.","Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",,195000,0,0,2021-04-19T16:37:30.117000-04:00
2605951,2b5ea278-8ae5-4753-a541-dede1cadfa42,Q1,"MEHLMAN CONSULTING, INC.",284950,AMNEAL,2021,first_quarter,PHA,Monitoring legislative and regulatory efforts related to domestic supply chains of generic drugs.,"Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",60000,,0,0,2021-04-19T17:13:19.467000-04:00
2606005,30546d6e-a17f-4576-9750-18caebae1a77,Q1,NATIONAL COMMUNITY PHARMACISTS ASSOCIATION,27478,NATIONAL COMMUNITY PHARMACISTS ASSOCIATION,2021,first_quarter,PHA,"S. 298 / H.R. 1829, the Pharmacy Benefit Manager Accountability Study Act of 2021;
Draft legislation, Vaccine Injury Compensation Modernization;
COVID vaccine distribution","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",,360000,0,0,2021-04-19T17:19:31.493000-04:00
2606080,2bc7e58c-f11c-47be-873b-8db933b366ae,Q1,"BLUE CROSS AND BLUE SHIELD OF KANSAS, INC.",323876,BLUE CROSS AND BLUE SHIELD OF KANSAS INC,2021,first_quarter,PHA,COVID-19 Testing; COVID-19 Vaccine Strategy and Treatment; Vaccine Rollout,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,5000,0,0,2021-04-19T17:25:45.263000-04:00
2606588,423ff54d-3ec1-4742-aebe-222ad776abc7,Q1,THE MATHIS HARPLE GROUP,322911,PILMA,2021,first_quarter,PHA,"Price Controls, Intellectual Property Rights","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2021-04-19T18:20:39.403000-04:00